Balances and Transactions With Related Parties and Key Officers

12 Months Ended

Dec. 31, 2022

Disclosure of transactions between related parties [abstract]

Balances And Transactions With Related Parties And Key Officers

Note 24:  Balances and Transactions With Related Parties and Key Officers

a. Related parties consist of:

• Clal Biotechnologies Industries Ltd.- Related party.

• Directors of the Company.

1. Balances of related parties:

	Other Payables
Related Party:
As of December 31, 2021		144
As of December 31, 2022		177
Directors:
As of December 31, 2021		96
As of December 31, 2022		130

2. Transactions with related parties:

Rental fee:	Year ended December 31
	2022		2021		2020
Related party		457		469		446

Professional fee *:	Year ended December 31
	2022		2021		2020
Directors		484		375		272
Related party		63		85		54
		547		460		326
Number of Directors		*10		8		8

* Not included share based compensation detailed in Note 19.

* During 2022 two members of the board of directors were replaced.

b. Key Officers:

1. Balances of Key Officers of the Company

	Other Payables
Key Officers of the Company
As of December 31, 2022		754
As of December 31, 2021		353

• Represents the officer’s gross salary, bonuses and vacation provisions without share based compensation.

2. Compensation of Key Officers of the Company:

The following amounts disclosed in the table are recognized as an expense during the reporting period related to officers:

	Year ended December 31
	2022		2021		2020
Short-term employee benefits (*)(**)		2,880		1,788		1,993
Share-based compensation		797		518		467
		3,677		2,306		2,460
Number of officers		7		5		5

(*) One-time expenses amounted $309 for the year ended December 31, 2022, are associated with the management changes.

(**) In December 2007, the Company's board of directors approved one‑time bonus payments to the Chief Medical Officer in the amounts of $120, which was recorded in profit and loss in December 2022 upon achieving marketing approval in the United States.